A Role for SCL in Developing Bone? the SCL +19 Core Enhancer Targets Expression to Cells of Developing Bone, Osteocytes, Chondrocytes and Bone Lining Cells.
Lev Silberstein(Massachusetts General Hospital), Anthony R. Green(Wellcome/MRC Cambridge Stem Cell Institute), Massimo Dominici(University of Modena and Reggio Emilia), Scott Oldham(Wellcome Sanger Institute), John E. Pimanda(Cancer Institute of New South Wales), Liz Delaney(University of Cambridge), Sandie Piltz(University of Cambridge), Berthold Göttgens(Wellcome/MRC Cambridge Stem Cell Institute), Stephen J. Brandt(Vanderbilt University Medical Center), Asha Kallianpur(Cleveland Clinic Lerner College of Medicine)
Cited by 0
Related Papers
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
<i>JAK2</i> Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
|New England Journal of Medicine|2007|1.2k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k